Health Care
UK Approves Pfizer/BioNTech Coronavirus Vaccine; Inoculation To Begin Next Week
The United Kingdom became the first country in the world to approve the highly-acclaimed Pfizer/BioNTech Coronavirus vaccine.
Setting the tone for mass inoculation, the new vaccine is reported to be 95 per cent effective in protecting people from COVID-19.
Read More: Top 5 Facts About Pfizer-BioNTech’s 90%-Effective COVID-19 Vaccine
As per the BBC, the MHRA – Britain’s medicine regulator – stated that the vaccine is 95 per cent effective, and that it is safe to be rolled out.
Eight hundred thousand doses are expected to be available in the UK from next week, and people will be contacted by the NHS for inoculation.
Priority will be given to the elderly, caregivers, and NHS staff – though a rounded priority list is expected to be released soon.
Pfizer had stated earlier in November that as much as 50 million vaccines would hit the global markets before the end of this year, while another 1.3 billion will be supplied to health professionals by 2021.
Named the BNT162b2, the mRNA-based vaccine was jointly developed by American pharmaceutical company Pfizer and German biotech company BioNTech.
Sources: BBC, Pfizer
-
OER Magazines2 months ago
OER, September 2024
-
Uncategorized1 month ago
Oman Oil Marketing Company partners with Ihsaan Association to support its activities
-
Commodities2 months ago
Gold Rangebound as Investors Brace for Key US Economic Data
-
OER Magazines3 weeks ago
Signature, October 24
-
Alamaliktistaad Magazines3 weeks ago
Al-iktisaad, October 24
-
Banking & Finance2 months ago
Apple Pay Officially Launched in Oman
-
Oil & Gas1 month ago
OQEP Appoints United Securities as Liquidity Provider Ahead of Landmark MSX Listing
-
Lifestyle2 months ago
Royal Opera House Muscat Welcomes First Shows of its 2024/25 Season